Winston-Salem clinical-stage company reports increase in cash, expenses during Q3 as result of going public

ProKidney, a clinical stage therapeutics company from Winston-Salem, reported that its cash at the end of the third quarter was up over $500 million from $20 million at the end of the fourth quarter 2021. The company also reported an increase in expenses as a result of going public with the "SPAC King" in July.